Clinical Trials Directory

Trials / Terminated

TerminatedNCT01666665

Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
36 (actual)
Sponsor
The University of Texas Medical Branch, Galveston · Academic / Other
Sex
All
Age
10 Years – 19 Years
Healthy volunteers
Not accepted

Summary

Massive pediatric burns are associated with a persistent and sustained hypermetabolic response characterized by elevated levels of circulating catecholamine's, cortisol, and glucagon's, which can cause extreme muscle wasting, immunodeficiency, and delay in wound healing. Insulin and metformin have demonstrated anabolic activity with minimal associated side effects. However, it is unknown whether the beneficial effects arise from tight euglycemic control or direct effect of insulin action. We hypothesize that during acute hospitalization, administration of metformin at a dose titrated to maintain blood glucose between 80-180 mg/dl will accelerate wound healing and recovery in children with severe thermal injury and will have beneficial long-term effects on muscle strength, immune function, and wound healing.

Detailed description

Metformin treated patients will be compared to control patients. Both groups will receive insulin therapy for blood glucose \>180mg/dl. Insulin will be titrated according to hospital sliding scale. The use of insulin or metformin will benefit burned children by improving muscle protein build-up, speeding wound healing and reversing growth arrest, improving the immune response, and positively affecting long-term rehabilitation. The results of this study may initiate a change in standard of care as it is found that simply the reduction of blood glucose by metformin, improves patient outcomes as metformin can be administered without the added complication of hypoglycemia.

Conditions

Interventions

TypeNameDescription
DRUGMetforminMetformin up to 1000mg/m2 body surface area by mouth of feeding tube up to 3 times each day for 12 months
DRUGSugar pillSugar pill up to 3 times per day for 12 months

Timeline

Start date
2012-11-01
Primary completion
2018-08-01
Completion
2019-04-23
First posted
2012-08-16
Last updated
2019-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01666665. Inclusion in this directory is not an endorsement.